Neurogene (NGNE) Other financing activities (2014 - 2026)
Neurogene (NGNE) posted Other financing activities of $201000.0 for Q1 2026, up 331.03% on a QoQ basis from -$87000.0 in Q3 2025, and up 957.89% year-over-year from $19000.0 in Q1 2025.
Neurogene (NGNE) Other financing activities (2014 - 2026) Analysis & Trends
Neurogene's Other financing activities history runs 13 years deep, the most recent figure standing at $201000.0 for Q1 2026.
- Quarterly Other financing activities rose 957.89% year-over-year to $201000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $182000.0 (down 95.05% YoY) and the FY2024 annual result came in at $4.3 million, changed N/A from the prior year.
- Other financing activities was $201000.0 for Q1 2026 at Neurogene, up from -$87000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $3.2 million in Q3 2024 and bottomed at -$2.0 million in Q4 2023.
- A 5-year average of $304066.7 and a median of $71000.0 in 2022 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 2476.06% in 2023, while the deepest fall reached 3114.75% in 2023.
- Neurogene's Other financing activities stood at -$61000.0 in 2022, then tumbled by 3114.75% to -$2.0 million in 2023, then soared by 265.37% to $3.2 million in 2024, then slumped by 102.68% to -$87000.0 in 2025, then soared by 331.03% to $201000.0 in 2026.
- Business Quant data shows NGNE's Other financing activities at $201000.0 in Q1 2026, -$87000.0 in Q3 2025, and $68000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Sep 30, 2024 | 3.24 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 415,000.00 |
| Mar 31, 2024 | 629,000.00 |
| Mar 31, 2024 | 629,000.00 |
| Dec 31, 2023 | -1.96 Mn |
| Dec 31, 2023 | -1.96 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |